Cloning

Cloning is Mohnish Pabrai‘s explicit investment methodology: rather than generating original investment ideas, systematically identify who the best investors are and copy their portfolios and mental models. The philosophy concedes that original idea generation is one of the scarcest skills; the advantage it trades on is the ability to identify who possesses it. The method extends well beyond stock picks — Pabrai applies it to operating habits, philanthropy, and daily practice.

The investment case

The foundational tool is the SEC 13F filing, which requires institutional managers with over $100 million in US equity to disclose holdings quarterly. A concentrated fund with a long, audited track record — two to three positions, held for years — is a candidate for cloning. The logic: if the manager has demonstrated genuine skill over a decade, their disclosed positions carry much of the same research value as if you had done the work yourself, delivered to you for free.

Pabrai’s refinements:

Relationship-based cloning: monthly lunches with Leelu Govindarajulu, at Charlie Munger’s instruction, produced recommendations for Amore Pacific (80x) and Moutai (became the world’s most valuable spirits company at the time of purchase). The mistake on Amore Pacific was failing to ask Leelu to explain the thesis; Pabrai corrected this practice on Moutai.
Latent cloning: observing how Munger operates — arriving fifteen minutes early everywhere; replying by scribbling in pen on a print-out and faxing it back — and adopting the behaviours directly.
Dakshana: the entire philanthropy was cloned from another organisation that had figured out the model; Pabrai took the framework and applied Buffett’s principles for giving.

The ego barrier

Cloning requires an explicit admission: I am not the best generator of original investment ideas. This is a significant ego cost. The advantage it unlocks is proportional: you are copying the output of people who are demonstrably better than you at the specific task, and you receive it at zero incremental research cost. Pabrai’s framing is that cloning is simply the same logic as any other efficient allocation of attention — do the thing you are best at; import the rest.

The limits

You can clone an output without the underlying capability. Pabrai built an insurance company to clone Berkshire’s float model. He learned that insurance is fundamentally hard: the real cost of policies is unknown for five to ten years. Berkshire’s own insurance operations were disastrous from the 1960s through 1985, before Ajit Jain’s arrival. Pabrai could copy the structure (float-funded investing) but not the input capability. He eventually sold to Francis Chua, who proved a far more capable operator.

Cloning does not remove the error rate. Pabrai is emphatic that the best investors are wrong roughly half the time. Seritage — bought on a deep-value redevelopment thesis — was sold after Pabrai concluded the thesis was wrong: too many jurisdictions, too much management turnover, entitlement processes too slow. Alibaba was sold after the thesis changed. The discipline is the absence of sentimentality, not the absence of mistakes. Checklists and sounding boards (Leelu) are circuit-breakers for the animal spirits that cause investors to hold through fundamental thesis breaks.

The attractor field logic

Pabrai connects cloning to David Hawkins’s Power vs Force: once you have identified that the best idea generators are a small number of identified individuals, the task becomes building relationships with them or their networks. Trustworthiness compounds — Munger and Buffett choose their close relationships carefully, and having been admitted to their orbit is itself a form of compounding access to the best ideas and mental models. The ethics Pabrai credits as his competitive advantage are partly a prerequisite for the cloning strategy to work at its most powerful level.

Where mainstream views differ

Active managers resist the implication that their research output is largely replicable from 13F data. The counter-argument is that concentrated, long-duration positions by managers with audited decade-long records genuinely are the product of superior skill, not luck — and that the 45-day lag in 13F disclosure is not material for positions held for years.

Quality of execution: even knowing what Munger or Buffett own does not tell you when to buy, how much to size, or when to sell. Pabrai acknowledges this — his Leelu relationship adds the qualitative thesis that the raw 13F does not provide.